The management of benign non-infective pleural effusions – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Ioannis Psallidas - Customer Care Specialist - Dell Technologies | LinkedIn
Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled ...
APSR Bulletin
Pleural Research Day on Twitter: "Ioannis Psallidas next up: SIMPLE study - use of US lung sliding sign to determine chest drain removal post pleurodesis #PRD2017… https://t.co/D7D8odvjWd"
MTcourses The... - USI Master in International Tourism | Facebook
References in Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis - The Lancet Oncology
Ioannis Psallidas, MD, PhD, FCCP, Associate Professor - Global Clinical Head, Respiratory & Immunology - AstraZeneca | LinkedIn
PDF) A 63-year-old man with a recurrent right-sided pleural effusion | I. Psallidas - Academia.edu
Lungs for Living on Twitter: "Great talk on personalised medicine in mesothelioma by Ioannis Psallidas @UCLRespiratory today. It seems the genetics and biology of Meso is simpler than many other cancers yet
Ioannis Psallidas on Foursquare
Volume 154, Issue 5, Pages (November 2018) - ppt download
PDF) Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial
Pleural Research Day on Twitter: "Ioannis Psallidas next up: SIMPLE study - use of US lung sliding sign to determine chest drain removal post pleurodesis #PRD2017… https://t.co/D7D8odvjWd"
Ioannis Psallidas, MD, PhD, FCCP, Associate Professor - Global Clinical Head, Respiratory & Immunology - AstraZeneca | LinkedIn
Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial. - Abstract - Europe PMC
Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator | SpringerLink
Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial.,The Lancet Respiratory Medicine - X-MOL
Mutant KRAS promotes malignant pleural effusion formation | Nature Communications
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial - ScienceDirect
Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator | SpringerLink
Ioannis Psallidas | hosco.
Ioannis Psallidas | hosco.
Frontiers in Respiratory Medicine:: volume 1 | Bentham Science
Tumor Necrosis Factor-α Promotes Malignant Pleural Effusion | Cancer Research
TRANSLATIONAL PROJECTS IN PLEURAL DISEASE | Ioannis Psallidas | 1 updates | Research Project
